ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
The imbalance in the availability of vaccines and supply shortages may worsen without international cooperation for smooth distribution. (Source photo by Reuters)
Datawatch

Supply imbalance leaves 150m doses of COVID vaccine unused

Makers scramble to meet demand; situation may worsen if booster shots needed

MIO TOMITA, RYOSUKE HANADA and KOTARO HOSOKAWA, Nikkei staff writers | U.S.

TOKYO/SEOUL -- Imbalance in COVID-19 vaccine supply is deepening around the world. The U.S., EU and other nations that produce and export vaccines have surpluses totaling more than 150 million doses, while shortages have caused delays in vaccination in many countries in Asia. 

A mechanism under which countries having surplus vaccines supply them to those in need is indispensable to facilitate vaccination on a global scale. 

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more